Artal Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Artal Group’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,500	Closed	-$2.9M	–	119
2018 Q3	$2.9M	Buy	+2,500	New	+$2.3M	0.08%	89

Other funds holding HSTO

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Artal Group's HSTO Position: Q4 2018 in Review

Artal Group sold out of Histogen Inc. Common Stock (HSTO) in Q4 2018, closing a stake of 2,500 shares — an estimated $2.9M sold.

Artal Group first reported a position in HSTO in Q3 2018 and held it in 1 quarter. The position peaked at $2.9M in Q3 2018. 52 funds tracked by Wall St. Rank hold HSTO as of Q4 2018.

Artal Group reported no remaining Histogen Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Artal Group sold 2,500 Histogen Inc. Common Stock shares in Q4 2018, an estimated $2.9M.
Artal Group first reported a position in Histogen Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Artal Group's Histogen Inc. Common Stock position peaked at $2.9M in Q3 2018.
52 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2018.

Based on Artal Group's 13F filing for Q4 2018, filed 11 Feb 2019.